Product Launch (Blog)

Global Diabetic Lancing Device Market is Rising Exponentially at Rate of 10.28% During the Anticipated Period

The Global Diabetic Lancing Device Market is expected to rise at annual rate 10.28% in the forecast period of 2021 to 2028, and is expected to reach USD 1,742.01 million by 2028 due to the increase in prevalence of diabetes among the population in developed and developing countries.

On the other hand, increase in cost of advanced diabetes management devices and rise in traditional Chinese medicine as an alternative are expected to obstruct the market growth in the above mentioned forecast period. Lack of adherence of patients to recommended diabetes treatment guidelines is projected to challenge the diabetic lancing device market.

Diabetic Lancing Device Market Scenario

According to Data Bridge Market Research the markets for the diabetic lancing device market is escalating due to the rise in awareness regarding use of blood glucose monitoring devices and safety measure devices and increase in in prevalence of diabetic population. Additionally, rise in the awareness about blood glucose monitoring devices, and increasing healthcare expenditure positively affect the

Furthermore, rising research and development activities in the healthcare sector extends profitable opportunities to the market players.

Now the question is which are the other regions that diabetic lancing device market is targeting? Data Bridge Market Research has estimated Asia-Pacific is expected to witness significant growth in the forecast period of 2021 to 2028 owning to the presence of a large number of lancet manufacturers from emerging economies such as India, Japan, South Korea, and China in this region.

For more analysis on the diabetic lancing device market, request for a briefing with our analysts,

Diabetic Lancing Device Market Scope

The diabetic lancing device market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country-based analysis diabetic lancing device market is further analyzed based on maximum granularity into further segmentation. The diabetic lancing device market on the basis of type has been segmented into safety lancets and standard lancets. Based on gauge, the diabetic lancing device market is segmented into17/18g, 21g, 23g, 25g, 28g, 30g and others. Based on penetration depth, the diabetic lancing device market is segmented into 8 mm to 1.0 mm, 1 mm to 1.5 mm, 6 mm to 2.0 mm, 1 mm to 2.5 mm and 5 mm to 3.0 mm. The diabetic lancing device market is also segmented on the basis of application into hospitals & clinics, home care & home diagnostics, diagnostic centers & medical institutions, research & academic laboratories and others.
  • Diabetes refers to a disease which occurs due to high blood glucose levels. Lancing device also known as a blood sampling device, mostly used by diabetics during blood glucose monitoring, and the device is fitted out with a lancet.

To know more about the study, please click on the below mentioned link,

Key Pointers Covered in the Diabetic Lancing Device Market Industry Trends and Forecast to 2028

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Regulatory Framework and Changes
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

 Key Market Competitors Covered in the report

  • BD
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • Sanofi, Novo Nordisk A/S
  • Ypsomed Holding
  • Ascensia Diabetes Care Holdings AG
  • Dexcom, Inc.
  • ARKRAY USA, Inc.
  • Bayer AG
  • Amylin Pharmaceuticals Inc.
  • Abbott, Medtronic Inc.
  • Teva Pharmaceuticals Pvt Ltd.
  • Home Diagnostics Inc.
  • Novartis AG
  • Eli Lilly and Company
  • Merck & Co., Inc
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Terumo Corporation

Above are the key players covered in the report, to know about more and exhaustive list of diabetic lancing device companies contact,

Research Methodology: Global Diabetic Lancing Device Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@

Client Testimonials